|1.||Petruska, Paul J: 2 articles (01/2011 - 05/2010)|
|2.||Fesler, Mark J: 2 articles (01/2011 - 05/2010)|
|3.||Osman, Medhat: 1 article (01/2011)|
|4.||Glauber, James: 1 article (01/2011)|
|5.||Di Bisceglie, Adrian M: 1 article (05/2010)|
|6.||Becker-Koepke, Stephanie: 1 article (05/2010)|
|7.||Lois, Vivian: 1 article (03/2007)|
|8.||Merino, Carlos: 1 article (03/2007)|
|9.||Cabrera, M Elena: 1 article (03/2007)|
|10.||Rojas, Hernán: 1 article (03/2007)|
|1.||Hodgkin Disease (Hodgkin's Disease)
05/01/1993 - "C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil."
03/16/1981 - "[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)]."
09/01/1987 - "[Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B]."
01/01/1993 - "We analysed the effect of chemotherapy dose reductions on survival in 35 patients with Hodgkin's disease stage IIIB or IV treated at our institution by three double courses of C-MOPP/ABVD chemotherapy followed by either one further course or by involved-field radiotherapy. "
02/01/1984 - "[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)]."
|2.||Non-Hodgkin Lymphoma (Lymphosarcoma)
01/01/1991 - "Our results indicate that ProMACE-C-MOPP is an effective regimen for intermediate-grade lymphomas. "
07/01/1988 - "[Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP]."
01/01/1991 - "ProMACE-C-MOPP in aggressive non-Hodgkin's lymphoma. "
06/01/1987 - "[C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)]."
01/01/2011 - "C-MOPP is a chemotherapy regimen for the treatment of Non-Hodgkin lymphoma (NHL). "
|3.||Burkitt Lymphoma (Burkitt's Lymphoma)
03/01/1985 - "Studies conducted at the NCI demonstrated that 47% of all patients with advanced stages of diffuse mixed, large cell, and undifferentiated non-Burkitt's lymphoma could achieve a complete remission documented by reevaluation of all initially involved sites following treatment with either the C-MOPP or BACOP combination chemotherapy regimens. "
06/01/1980 - "[Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. "
03/01/2000 - "Between October 1989 and February 1993, a multicenter phase II study of alternating CCT C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, vinblastine, bleomycin, dacarbazine) to evaluate its clinical usefulness for clinical stage (cS) II-IV HD was conducted by the Lymphoma Study Group of the Japan Clinical Oncology Group. "
03/01/2007 - "C-MOPP/ABVD, C-MOPP/ABV and ABVD had comparable results and reached a high tumor control and overall survival in both early and advanced stages."
01/01/2011 - "We retrospectively report the results of C-MOPP-R treatment for follicular lymphoma at Saint Louis University Cancer Center from 2000-2009. "
03/01/2006 - "Three years prior the surgery for intracranial tumor, the patient had been started to be treated for HD of neoplasm stage I (NS I) type, by the use of the standard (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) BEA-COPP protocol. "
|7.||Vinblastine (Vinblastine Sulfate)
|1.||Combination Drug Therapy (Combination Chemotherapy)
|2.||Drug Therapy (Chemotherapy)